For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...

Data presented at the 2025 Crohn's and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...

Bio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.

Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

While the rising incidence is due in part to environmental factors including ultra-processed foods and smoking, the ...

HC Wainwright reissued their buy rating on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a report released on ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing ...

Until her mid-40s Lisa O'Brien gave little thought to what she ate - but suddenly certain foods started to trigger strange, ...

Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced the appointment of Dr. Laura Saward, PhD, as the company's Chief Scientific ...

Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in weight loss.